Whether you're buying a new home or considering mortgage refinancing, the main question is the same right now: When will rates drop? The interest rate environment has remained elevated across various ...

Combivent Respimat is available only as a brand-name medication and not available in generic form, according to Medical News Today, which pointed out that the actual price a patient would pay for ...

Boehringer Ingelheim announced that the FDA has approved Combivent Respimat (ipratropium bromide and albuterol), a propellant-free metered dose inhalation spray that uses a slow-moving mist, for ...

Boehringer Ingelheim announced that Combivent Respimat (ipratropium bromide and albuterol) inhalation spray is now available.

Active ingredients of dual-action Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol now delivered by new propellant-free inhaler RIDGEFIELD, Conn., Oct. 10, 2011 | Active ...

Two asthma inhalers are being phased out, the Food and Drug Administration announced at the end of May. The Combivent Inhalation Aerosol and the Maxair Autohaler both contain chlorofluorocarbons ...

The FDA has approved revisions to the safety labeling for ipratropium bromide and albuterol sulfate inhalation aerosol, quinine sulfate capsules, and sacrosidase oral solution.

Ipratropium plus albuterol delivered by spray is as safe as metered-dose inhaler in patients chronic obstructive pulmonary disease.

Boehringer Ingelheim will cap out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma at $35 per month starting June 1, the German drugmaker said on Thursday.

Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has been hit with a prospective class action lawsuit that alleges its Combivent asthma inhaler provides far less than the number of ...

One international pharmaceutical company charges $489 for brand name inhaler Combivent Respimat in the United States but just $7 in France.